著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Hai-Dong Zhu and Hai-Liang Li and Ming-Sheng Huang and Wei-Zhu Yang and Guo-Wen Yin and Bin-Yan Zhong and Jun-Hui Sun and Zhi-Cheng Jin and Jian-Jian Chen and Nai-Jian Ge and Wen-Bin Ding and Wen-Hui Li and Jin-Hua Huang and Wei Mu and Shan-Zhi Gu and Jia-Ping Li and Hui Zhao and Shu-Wei Wen and Yan-Ming Lei and Yu-Sheng Song and Chun-Wang Yuan and Wei-Dong Wang and Ming Huang and Wei Zhao and Jian-Bing Wu and Song Wang and Xu Zhu and Jian-Jun Han and Wei-Xin Ren and Zai-Ming Lu and Wen-Ge Xing and Yong Fan and Hai-Lan Lin and Zi-Shu Zhang and Guo-Hui Xu and Wen-Hao Hu and Qiang Tu and Hong-Ying Su and Chuan-Sheng Zheng and Yong Chen and Xu-Ya Zhao and Zhu-Ting Fang and Qi Wang and Jin-Wei Zhao and Ai-Bing Xu and Jian Xu and Qing-Hua Wu and Huan-Zhang Niu and Jian Wang and Feng Dai and Dui-Ping Feng and Qing-Dong Li and Rong-Shu Shi and Jia-Rui Li and Guang Yang and Hai-Bin Shi and Jian-Song Ji and Yu-E Liu and Zheng Cai and Po Yang and Yang Zhao and Xiao-Li Zhu and Li-Gong Lu and Gao-Jun Teng,Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001),Signal Transduction and Targeted Therapy,2059-3635,Springer Science and Business Media LLC,2023-02-08,8,1,,https://cir.nii.ac.jp/crid/1360580935792987776,https://doi.org/10.1038/s41392-022-01235-0